Human ProNGF: Biological effects and binding profiles at TrkA, P75 NTR and sortilin

Journal of Neurochemistry

Volumn 107, Issue 4, 2008, Pages 1124-1135

  Clewes, Oliver ^a   Fahey, Mark S ^a   Tyler, Sue J ^a   Watson, Judy J ^a   Seok, Heon ^a   Catania, Caterina ^a   Cho, Kwangwook ^a   Dawbarn, David ^a,b   Allen, Shelley J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Dorothy Hodgkin Building ^*  (United Kingdom)

Author keywords

Nerve growth factor; Neurotrophin; p75NTR; Pro nerve growth factor; Sortilin; Tyrosine kinase receptor A

Indexed keywords

CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTOR; NEUROTENSIN RECEPTOR; NEUROTROPHIN RECEPTOR; NEUROTROPHIN RECEPTOR P75; PROTEIN TYROSINE KINASE A; SORTILIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL SURVIVAL; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANIMALS, NEWBORN; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTATION; NERVE GROWTH FACTOR; NEURITES; NEURONS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PRECURSORS; RADIOLIGAND ASSAY; RATS; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 54349117308     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05698.x     Document Type: Article

References (37)

1. Allen S. J., Dawbarn D., MacGowan S. H., Wilcock G. K., Treanor J. Moss T. H. (1990) A quantitative morphometric analysis of basal forebrain neurons expressing NGF receptors in normal and Alzheimer's disease brain. Dementia 1, 125 137.
2. Allen S. J., Robertson A. G., Tyler S. J., Wilcock G. K. Dawbarn D. (2001) Recombinant human nerve growth factor for clinical trials: protein expression, purification, stability and characterisation of binding to infusion pumps. J. Biochem. Biophys. Methods 47, 239 255.
3. Althaus H. H. Kloppner S. (2006) Mature pig oligodendrocytes rapidly process human recombinant pro-nerve growth factor and do not undergo cell death. J. Neurochem. 98, 506 517.
4. Beattie M. S., Harrington A. W., Lee R., Kim J. Y., Boyce S. L., Longo F. M., Bresnahan J. C., Hempstead B. L. Yoon S. O. (2002) ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36, 375 386.
5. Boutilier J., Ceni C., Pagdala P. C., Forgie A., Neet K. E. Barker P. A. (2008) Proneurotrophins require endocytosis and intracellular proteolysis to induce TRKA activation. J. Biol. Chem. 283, 12709 12716.
6. Cheng Y. Prusoff W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099 3108.
7. Cho K., Kemp N., Noel J., Aggleton J. P., Brown M. W. Bashir Z. I. (2000) A new form of long-term depression in the perirhinal cortex. Nat. Neurosci. 3, 150 156.
8. Clos J. Dicou E. (1997) Two peptides derived from the nerve growth factor precursor enhance cholinergic enzyme activities in vivo. Brain Res. Dev. Brain Res. 99, 267 270.
9. Dicou E. (2006) Multiple biological activities for two peptides derived from the nerve growth factor precursor. Biochem. Biophys. Res. Commun. 347, 833 837.
10. Fahnestock M., Michalski B., Xu B. Coughlin M. D. (2001) The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol. Cell. Neurosci. 18, 210 220.
11. Fahnestock M., Yu G., Michalski B., Mathew S., Colquhoun A., Ross G. M. Coughlin M. D. (2004) The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor. J. Neurochem. 89, 581 592.
12. Ginsberg S. D., Che S., Wuu J., Counts S. E. Mufson E. J. (2006) Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J. Neurochem. 97, 475 487.
13. Harrington A. W., Leiner B., Blechschmitt C., Arevalo J. C., Lee R., Morl K., Meyer M., Hempstead B. L., Yoon S. O. Giehl K. M. (2004) Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc. Natl Acad. Sci. USA 101, 6226 6230.
14. Hempstead B. L., Martin-Zanca D., Kaplan D. R., Parada L. F. Chao M. V. (1991) High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 350, 678 683.
15. Holden P. H., Asopa V., Robertson A. G. et al. (1997) Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor. Nat. Biotechnol. 15, 668 672.
16. Kaplan D. R. Miller F. D. (2000) Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10, 381 391.
17. Kliemannel M., Rattenholl A., Golbik R., Balbach J., Lilie H., Rudolph R. Schwarz E. (2004) The mature part of proNGF induces the structure of its pro-peptide. FEBS Lett. 566, 207 212.
18. Kliemannel M., Golbik R., Rudolph R., Schwarz E. Lilie H. (2007) The pro-peptide of proNGF: structure formation and intramolecular association with NGF. Protein Sci. 16, 411 419.
19. Lee R., Kermani P., Teng K. K. Hempstead B. L. (2001) Regulation of cell survival by secreted proneurotrophins. Science 294, 1945 1948.
20. Liepinsh E., Ilag L. L., Otting G. Ibanez C. F. (1997) NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J. 16, 4999 5005.
21. Mobley W. C., Schenker A. Shooter E. M. (1976) Characterization and isolation of proteolytically modified nerve growth factor. Biochemistry 15, 5543 5552.
22. Moore J. B. Jr., Mobley W. C. Shooter E. M. (1974) Proteolytic modification of the beta nerve growth factor protein. Biochemistry 13, 833 840.
23. Noel J., Ralph G. S., Pickard L., Williams J., Molnar E., Uney J. B., Collingridge G. L. Henley J. M. (1999) Surface expression of AMPA receptors in hippocampal neurons is regulated by an NSF-dependent mechanism. Neuron 23, 365 376.
24. Nykjaer A., Lee R., Teng K. K. et al. (2004) Sortilin is essential for proNGF-induced neuronal cell death. Nature 427, 843 848.
25. Pagadala P. C., Dvorak L. A. Neet K. E. (2006) Construction of a mutated pro-nerve growth factor resistant to degradation and suitable for biophysical and cellular utilization. Proc. Natl Acad. Sci. USA 1031, 17939 17943.
26. Paoletti F., Konarev P. V., Covaceuszach S., Schwarz E., Cattaneo A., Lamba D. Svergun D. I. (2006) Structural and functional properties of mouse proNGF. Biochem. Soc. Trans. 34, 605 606.
27. Peleshok J. Saragovi H. U. (2006) Functional mimetics of neurotrophins and their receptors. Biochem. Soc. Trans. 34, 612 617.
28. Petersen C. M., Nielsen M. S., Nykjaer A., Jacobsen L., Tommerup N., Rasmussen H. H., Roigaard H., Gliemann J., Madsen P. Moestrup S. K. (1997) Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J. Biol. Chem. 272, 3599 3605.
29. Rattenholl A., Lilie H., Grossmann A., Stern A., Schwarz E. Rudolph R. (2001a) The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies. Eur. J. Biochem. 268, 3296 3303.
30. Rattenholl A., Ruoppolo M., Flagiello A., Monti M., Vinci F., Marino G., Lilie H., Schwarz E. Rudolph R. (2001b) Pro-sequence assisted folding and disulfide bond formation of human nerve growth factor. J. Mol. Biol. 305, 523 533.
31. Rehm M., Dussmann H., Janicke R. U., Tavare J. M., Kogel D. Prehn J. H. (2002) Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process. Role of caspase-3. J. Biol. Chem. 277, 24506 24514.
32. Robertson A. G., Banfield M. J., Allen S. J. et al. (2001) Identification and structure of the nerve growth factor binding site on TrkA. Biochem. Biophys. Res. Commun. 282, 131 141.
33. Seidah N. G., Benjannet S., Pareek S., Savaria D., Hamelin J., Goulet B., Laliberte J., Lazure C., Chretien M. Murphy R. A. (1996) Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochem. J. 314 (Pt. 3 951 960.
34. Suter U., Heymach J. V. Jr. Shooter E. M. (1991) Two conserved domains in the NGF propeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NGF. EMBO J. 10, 2395 2400.
35. Treanor J. J., Dawbarn D., Allen S. J., MacGowan S. H. Wilcock G. K. (1991) Low affinity nerve growth factor receptor binding in normal and Alzheimer's disease basal forebrain. Neurosci. Lett. 121, 73 76.
36. Volosin M., Song W., Almeida R. D., Kaplan D. R., Hempstead B. L. Friedman W. J. (2006) Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins. J. Neurosci. 26, 7756 7766.
37. Wehrman T., He X., Raab B., Dukipatti A., Blau H. Garcia K. C. (2007) Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron 53, 25 38.